Metastatic Hormone Refractory Prostate Cancer Recruiting Phase 3 Trials for DCFPyL F-18 (DB14805)

Also known as: Metastatic hormone refractory Prostate cancer / Metastatic Prostate cancer / Prostate cancer metastatic / Metastatic Prostate Carcinoma / Carcinoma of the prostate metastatic / Prostatic cancer metastatic

IndicationStatusPhase
DBCOND0036371 (Metastatic Hormone Refractory Prostate Cancer)Recruiting3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03739684Study of 18F-DCFPyL PET/CT Imaging in Patients With Suspected Recurrence of Prostate CancerDiagnostic